Source: MobiHealthNews

The Analytic for Hemodynamic Instability tool can identify hemodynamic instability with 96% sensitivity and detects stable patients with 85% specificity.

Read the full article >

Source: Fifth Eye Inc.

Fifth Eye’s noninvasive tool is the first to provide continuous monitoring of hemodynamic status using a single ECG lead

Read the full article >

Source: HealthITAnalytics

Researchers from Michigan Medicine and Fifth Eye have developed a predictive analytics tool that can alert providers which patients are at risk of deteriorating.

Read the full article >

Source: Healthcare Innovation

The venture capital-backed startup, Ann Arbor-based Fifth Eye, has developed a noninvasive clinical tool called Analytic for Hemodynamic Instability (AHI), which it says is the first solution to establish real-time streaming data for early onset hemodynamic instability. A research study on the solution was first published in November 2020 by the International Journal of Medical Health Sciences and was recently awarded “Best Paper” at the 2020 International Conference on Health Analytics. The company is now awaiting approval from the U.S. Food & Drug Administration before marketing it to other health systems.

Read the full article >

New peer-reviewed research by Fifth Eye and Michigan Medicine awarded best paper at international conference on health analytics.

New research shows a groundbreaking clinical tool, in development by Fifth Eye and Michigan Center for Integrative Research in Critical Care (MCIRCC), can reliably alert clinicians that a patient is at risk of developing hemodynamic instability — one of the most common causes of death for critically injured or ill patients — well before they deteriorate. This allows for earlier intervention before the patient progresses to cardiac arrest, organ injury, or other serious adverse events.

Read the full press release >

The Ann Arbor Entrepreneurs Fund (A2EF) supports entrepreneurs and investors by connecting them with their peers and the community and provides a platform for them to give back to Washtenaw County through equity donations. A2EF is excited to recognize the leadership and generosity of Jen Baird, Kathleen Craig, Marianna Kerppola and Evan Ufer, in pledging 1% of their equity to the A2EF endowment fund at the Ann Arbor Area Community Foundation.

Read the full article >

Fifth Eye’s software is designed to act as an early warning system to predict when a patient might be in imminent trouble, based on their electrocardiogram (ECG) data. When the heart overcompensates for other trouble in the body, the signs are subtle, Baird says, but they have detectable mathematical characteristics, which helps the company’s software to assess the patient’s condition.

Read the full article >

Fifth Eye uses continuous physiologic waveforms to build clinical early warning systems that enable proactive patient care to improve outcomes, avoid adverse events, shorten lengths of stay and reduce healthcare costs. The financing will be used to secure FDA clearance of Fifth Eye’s first product, support clinical studies with multiple health systems, and enable commercial launch of the company’s first product, the Analytic for Hemodynamic Instability.

Read the full article >

“Despite continued advances in healthcare technology, clinicians do not have adequate tools that allow them to consistently identify patients prior to rapid worsening of their clinical condition,” Tom Shehab, a physician and managing partner at Arboretum, told Crain’s. “The Fifth Eye technology has the potential to provide early warning of hemodynamic collapse (and) allows clinicians the opportunity to intervene and improve patient outcomes.”

Read the full article >